TEZSPIRE – Newest FDA-Approved Biologic for Severe Asthma
Returning guest, Dr. Neal Jain discusses asthma, severe asthma, and AstraZeneca and Amgen’s Tezspire™ (tezepelumab-ekko), the newest FDA-approved biologic for severe asthma. He is joined by a patient that shares their experience with severe asthma.
Dr. Neal Jain obtained his medical degree from the Medical College of Wisconsin. Trained in Pediatrics at the Phoenix Children’s Hospital, he served there as chief resident from 2001 to 2002. He has trained in Allergy, Asthma, and immunology at the National Jewish Health Center where he was appointed Chief Fellow, and University of Colorado School of Medicine in Denver. Dr. Jain has been an active member of the community, proudly serving as President of the Arizona Allergy Society and a fellow of the American Academy of Allergy, Asthma, & Immunology and Pediatrics.
